Literature DB >> 21256280

Outcomes of minimally invasive valve surgery versus standard sternotomy in obese patients undergoing isolated valve surgery.

Orlando Santana1, Javier Reyna, Robert Grana, Mauricio Buendia, Gervasio A Lamas, Joseph Lamelas.   

Abstract

BACKGROUND: We hypothesize that composite in-hospital surgical complications are lower in obese patients who undergo minimally invasive valve surgery for aortic and (or) mitral valve disease, when compared with the standard median sternotomy approach.
METHODS: We retrospectively reviewed 2,288 heart operations done at our institution between January 3, 2005 and January 10, 2010, and identified 160 consecutive obese patients, defined as patients with a body mass index of greater than 30 kg/m(2), who underwent isolated mitral and (or) aortic valve surgery. The outcomes of those who had minimally invasive valve surgery were compared with a matched control group who had valve surgery through a median sternotomy approach.
RESULTS: Of the 160 patients, 64 underwent the minimally invasive approach and 96 had a median sternotomy. The mean age was 69.4 ± 11 years for the minimally invasive group, and 64.7 ± 11.5 for the median sternotomy group (p = 0.015). Composite postoperative complications occurred in 15 (23.49%) versus 49 (51.0%) patients (p = 0.034) in the minimally invasive group versus median sternotomy, respectively. The difference was driven by a lower incidence of acute renal failure (0 vs 6 patients [6.25%], p = 0.041), prolonged intubation (12 [18.7%] vs 33 [34.3%], p = 0.049), reintubation (3 [4.68%] vs 15 [15.6%], p = 0.032), deep wound infections (0 vs 4 [4.1%], p = 0.098), and death (0 vs 8 [8.3%], p = 0.041), respectively. All patients in the minimally invasive group were alive at 30 days.
CONCLUSIONS: Minimally invasive surgery for isolated valve lesions in obese patients has a lower morbidity and mortality when compared with the standard median sternotomy approach. Copyright Â
© 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21256280     DOI: 10.1016/j.athoracsur.2010.09.039

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  30 in total

Review 1.  Minimally invasive heart valve surgery: how and why in 2012.

Authors:  Rakesh M Suri; Nassir M Thalji
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Endoscopic thyroidectomy is safe in patients with a high body mass index.

Authors:  William S Duke; Jennifer R White; Jennifer L Waller; David J Terris
Journal:  Thyroid       Date:  2014-05-21       Impact factor: 6.568

3.  Minimally invasive mitral valve surgery is associated with excellent resource utilization, cost, and outcomes.

Authors:  Robert B Hawkins; J Hunter Mehaffey; Samuel M Kessel; Jolian J Dahl; Irving L Kron; John A Kern; Leora T Yarboro; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2018-04-03       Impact factor: 5.209

Review 4.  Concomitant minithoracotomy aortic and mitral valve surgery: the minimally invasive "Miami Method".

Authors:  Joseph Lamelas
Journal:  Ann Cardiothorac Surg       Date:  2015-01

Review 5.  Minimally invasive concomitant aortic and mitral valve surgery: the "Miami Method".

Authors:  Joseph Lamelas
Journal:  Ann Cardiothorac Surg       Date:  2015-01

6.  Outcomes of minimally invasive double valve surgery.

Authors:  Orlando Santana; Steve Xydas; Roy F Williams; Angelo LaPietra; Maurice Mawad; Frederick Hasty; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 7.  Minimally invasive mitral valve repair.

Authors:  Mateo Marin Cuartas; Piroze Minoo Davierwala
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-07-27

Review 8.  Aortic Valve Surgery: Minimally Invasive Options.

Authors:  Basel Ramlawi; Kareem Bedeir; Joseph Lamelas
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Jan-Mar

9.  Minimally invasive mitral valve surgery in high-risk patients: operating outside the boxplot.

Authors:  Marco Moscarelli; Alfredo Cerillo; Thanos Athanasiou; Pierandrea Farneti; Giacomo Bianchi; Rafik Margaryan; Marco Solinas
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-06

10.  Is minimally invasive thoracoscopic surgery the new benchmark for treating mitral valve disease?

Authors:  Andrew B Goldstone; Y Joseph Woo
Journal:  Ann Cardiothorac Surg       Date:  2016-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.